UC Neuroscience Institute Adds Neurobiology Research Center
CINCINNATIThe University of Cincinnati Neuroscience Institute (UCNI) today announced a new Center of Excellence, the UC Neurobiology Research Center, designed to provide a focal point for basic, discovery-based neuroscience.
The announcement was made by UCNI Director Joseph Broderick, MD, a professor in the UC Department of Neurology and Rehabilitation Medicine and UC Health neurologist, who said creation of the center highlights the importance of discovery to UCNIs mission of education, research and treatment.
"Part of the UC Neurobiology Research Centers vision will be to serve as a focal point for integration of clinical and basic science research programs, Broderick said.
The center, under the direction of James Herman, PhD, a professor in the UC Department of Psychiatry and Behavioral Neuroscience, becomes the 11th center within UCNI, one of four institutes of the UC College of Medicine and UC Health. Earlier this month, the UC Neuromuscular Center became UCNIs 10th center. UCNI also includes three programs.
"The goal of the UC Neurobiology Research Center will be to create and nurture relationships between basic and clinical research, with a translational (bench to bedside) emphasis, Herman said. "This will involve collaborations between basic and clinical researchers that exist within the other centers of UCNI. This center is also a focal point for recruitment of new neuroscientists at the University of Cincinnati as well as further enhancement of an already strong Neuroscience Graduate Training Program, a focal point of investment by the UC2019 program.
Strong collaborative relationships already exist in several centers, Herman said, including the Gardner Family Center for Parkinsons Disease and Movement Disorders where basic science researchers such as Herman and Kim Seroogy, PhD, collaborate with clinicians such as Fredy Revilla, MD, and Alberto Espay, MD. The goal would be to foster even more collaborations, extending them to fundraising and awareness in addition to research.
"Additionally, the center will seek to fund pilot projects that have potential for extramural funding and promote career growth for our faculty, Herman said.
Broderick said the center will be launched with four to six new pilot grants of $25,000 each. UC faculty and senior fellows will compete for the grants, which will emphasize collaboration between basic researchers and clinicians.
"The pilot grant program is open to all UC faculty and senior fellows, with the goal of creating research teams that can submit successful grant programs to the National Institutes of Health, Broderick said.
"Were trying to create teams that can help move forward not only clinical science but also basic science in parallel so that what were doing here at UCNI is not only treating patients but also creating new opportunities for curesfinding out what the underlying mechanisms of disease are and using that information to move forward to next steps for finding cures and treatments.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.